Part 8 · Chapter 28

Pulsed Electric Field Applications

The previous chapter built the machines that deliver a microsecond burst of high voltage. This one points that burst at something unexpected: a living cell. Apply a strong enough electric field for a few microseconds and the cell's membrane springs open with pores — electroporation — without heating the cell at all. That single non-thermal effect, dialled up or down, lets pulsed electric fields pasteurise juice without cooking it, disinfect water without chemicals, attack the antibiotic resistance hiding in wastewater, and ablate a tumour while sparing the vessels beside it. Here we follow the field from the membrane it charges to the industries and clinics it is transforming.

High-Voltage Engineering Prof. Mithun Mondal Reading time ≈ 50 min
i What you'll learn
  • The electroporation mechanism and why PEF treatment is non-thermal, plus reversible versus irreversible poration.
  • The induced transmembrane voltage and the Schwan equation \(\Delta V_m = 1.5\,rE\cos\theta(1-e^{-t/\tau})\), with its \(\sim1~\mathrm{V}\) threshold.
  • The membrane charging time constant and the pulse parameters — field, duration, number, shape, specific energy.
  • The inactivation kinetics of microbes by the log-linear, Hülsheger and Weibull models.
  • The design of treatment chambers, the energy dose and the temperature rise that must be controlled.
  • Applications in food, in water and wastewater and the antimicrobial-resistance frontier, and in biomedicine.
Section 28-1

From Pulses to Cells

A biological cell is a tiny bag of conducting fluid wrapped in a thin, almost perfectly insulating membrane. Place that cell in a strong external electric field and the field cannot penetrate the conducting interior, so it piles up across the insulating membrane, charging it like a capacitor. If the field is strong enough, the voltage that appears across the membrane becomes too great for it to bear, and the membrane breaks down into a population of tiny aqueous pores. This is electroporation — and it is the single phenomenon behind every application in this chapter.

Its great virtue is that it is non-thermal. The pulses are so brief that they barely heat the fluid, yet they permeabilise the membrane completely — so PEF can kill a microbe or open a cell without cooking it, preserving the flavours, vitamins and proteins that heat would destroy. Whether the effect is benign or lethal depends on the dose. A gentle treatment opens pores that later reseal: reversible electroporation, used to slip drugs or genes into a living cell. A harsh treatment opens pores that never close, and the cell leaks its contents and dies: irreversible electroporation, the basis of microbial inactivation and tumour ablation. One mechanism, two outcomes, set by the strength and number of pulses.

applied field E resealing reversible: cell lives leaking irreversible: cell dies
Electroporation, two outcomes — the field charges the membrane and opens pores; a gentle dose lets them reseal (reversible, the cell survives), a strong dose leaves them open (irreversible, the cell dies). Both are non-thermal
Section 28-2

The Schwan Equation

How much voltage does an external field actually impose on the membrane? For a spherical cell of radius \(r\) in a uniform field \(E\), the answer is the Schwan equation, which gives the induced transmembrane voltage as a function of position and time:

Induced transmembrane voltage (Schwan)
\[ \Delta V_m = 1.5\,r\,E\,\cos\theta\,\big(1 - e^{-t/\tau}\big) \]
uniform field E → + r θ ΔV_m greatest at the poles (θ=0), zero at the equator
The Schwan picture — the field drives charge to the two poles of the cell, inducing a transmembrane voltage \(1.5\,rE\) at the poles (\(\theta=0\)) that falls to zero at the equator; the membrane charges up over a time constant \(\tau\)

Three features of this little equation drive everything. The factor \(1.5\) is the geometry of a sphere; the \(\cos\theta\) means the voltage is greatest at the two poles that face along the field and zero at the equator, so poration starts at the poles; and the \((1-e^{-t/\tau})\) says the membrane charges up over a time constant \(\tau\) and the pulse must outlast it. Permeabilisation begins once \(\Delta V_m\) reaches a threshold of roughly \(0.2\)–\(1~\mathrm{V}\). The crucial practical consequence hides in the factor \(r\): because \(\Delta V_m\propto r\), large cells porate at low fields and small cells need high fields. A large mammalian cell electroporates at well under a kilovolt per centimetre, but a tiny, tough bacterium — the target in water and wastewater — needs tens of kilovolts per centimetre, which is exactly why microbial PEF runs at such fierce field strengths.

Section 28-3

Pulse Parameters and Charging

The membrane charges through the resistance of the fluid inside and outside the cell, with a charging time constant

Membrane charging time constant
\[ \tau \approx r\,C_m\left(\rho_i + \tfrac{1}{2}\rho_e\right) \]
t → field pulse E ΔV_m (1−e^(−t/τ)) threshold ≈ 1 V
Pulse and membrane charging — a square field pulse drives the membrane voltage up along \((1-e^{-t/\tau})\); poration begins once it crosses the threshold, so an effective pulse must comfortably outlast the charging time \(\tau\)

For a bacterium this \(\tau\) is only tens of nanoseconds, so a conventional microsecond pulse charges the membrane fully many times over. The treatment is then specified by a handful of pulse parameters: the field strength \(E\) (the single most important, since it sets whether \(\Delta V_m\) clears the threshold at all); the pulse duration and number of pulses (which set how long the membrane is held open); the pulse shape (square pulses deliver the field more efficiently than decaying exponential ones); the repetition frequency; and, summarising them all, the specific energy delivered per unit mass of fluid. Designing a PEF process is choosing these numbers so the target organisms are inactivated while the energy — and the heating it causes — stays acceptably low.

Section 28-4

Inactivation Kinetics

How many microbes a treatment kills is expressed as a log reduction: the base-ten logarithm of the surviving fraction \(s = N/N_0\). A "5-log" treatment leaves one organism in \(100{,}000\). Three models describe how that survival depends on the field and time, in rising order of realism.

0 −6 log(N/N₀) treatment time / dose → log-linear Weibull (shoulder) tail
Survival curves — the log-linear model is a straight line on a semi-log plot, but real PEF data often curve, with an initial resistant shoulder and a stubborn surviving tail that the flexible Weibull model captures

The simplest is the log-linear (first-order) law, \(\log_{10}(N/N_0) = -t/D\), where \(D\) is the time (or pulse count) for one decade of kill — a straight line on a semi-log plot. Real data rarely stay straight, so the Weibull model, \(\log_{10}(N/N_0) = -(t/\delta)^{p}\), adds a shape factor \(p\) to bend the curve, capturing the resistant shoulder at the start and the stubborn surviving tail at the end. And to bring in the field explicitly, the classic Hülsheger model expresses survival in terms of a critical field \(E_c\) and critical time \(t_c\), below which nothing happens:

Hülsheger model
\[ s = \left(\frac{t}{t_c}\right)^{-(E-E_c)/k} \qquad\Longrightarrow\qquad \log s = -\frac{E-E_c}{k}\,\log\!\frac{t}{t_c} \]

Here inactivation switches on only once the field exceeds the threshold \(E_c\) (the small-cell, high-field threshold of the Schwan equation) and the time exceeds \(t_c\); beyond those, survival falls as a power of the treatment time, steeper the further \(E\) is pushed above \(E_c\). These models turn a microbiology experiment into design numbers — the field and dose needed to reach a target log reduction — and are the everyday tools of PEF process design.

Section 28-5

The Treatment Chamber and Dose

The field has to be delivered to a flowing fluid, and that is the job of the treatment chamber — a pair of electrodes between which the liquid passes while the pulse generator (a Marx or solid-state source from Chapter 27) fires across them. The two common geometries are the parallel-plate chamber, simple and uniform but with the electrodes in the flow, and the co-field (tubular) chamber, where the field lies along the flow direction between insulating sections, keeping the electrodes out of the narrowest gap and easing fouling. Field uniformity matters, because any region below the threshold field simply does not treat the microbes passing through it.

in (N₀) out (N) electrode E = V/d pulse source
A flow-through PEF chamber — fluid passes between electrodes across which a pulsed-power source applies the field \(E=V/d\); microbes entering at \(N_0\) leave inactivated at \(N\), with the energy dose set by the field, pulse number and flow rate

The treatment intensity is captured by the specific energy \(W\) deposited per unit mass — a function of the field, the conductivity of the fluid, the pulse width and the number of pulses each parcel of liquid receives as it flows through. Typical microbial PEF runs at tens to a hundred or so kilojoules per kilogram. The same Joule heating that deposits this energy also warms the fluid, so a key design constraint is to keep the temperature rise small enough that the process stays genuinely non-thermal, usually by pre-cooling and by limiting the conductivity and the dose. The art of the chamber is to give every microbe a uniform, supra-threshold field and an adequate dose without boiling the broth.

Section 28-6

Food and Extraction

The oldest commercial home of PEF is the food industry, where its non-thermal kill is a gift. Pasteurising liquid foods — fruit juices, smoothies, milk, liquid egg — by PEF inactivates spoilage and pathogenic microbes while leaving the fresh taste, colour, vitamins and aroma that heat pasteurisation degrades, giving "fresh-like" products with extended shelf life. The same membrane breakdown serves a second purpose: cell-tissue disintegration for extraction. Porating the cells of plant tissue lets juice, sugar, oil, pigments or other valuable intracellular compounds flow out far more readily, raising yields and cutting the energy of pressing, drying and diffusion — used for sugar-beet processing, juice expression, wine maceration and the drying of fruits and vegetables. In food, PEF is thus both a gentle steriliser and an efficient cell-opener, the same physics turned to two ends.

Section 28-7

Water, Wastewater and the AMR Frontier

Pointed at water, PEF becomes a chemical-free disinfectant. Conventional chlorination kills microbes but leaves disinfection by-products; PEF inactivates bacteria by irreversible electroporation without adding anything to the water, an attractive option for sensitive supplies and for polishing treated effluent. Its frontier application, though, is one of the most pressing problems in environmental engineering: antimicrobial resistance (AMR). Wastewaters from hospitals, pharmaceutical fermentation and landfill leachate are reservoirs of antibiotic-resistant bacteria and the antibiotic-resistance genes (ARGs) they carry, and conventional treatment lets many of them escape into the environment, where the genes can spread between organisms.

Killing the cell is not the same as destroying the gene. This is the subtlety at the heart of PEF for AMR. A field that inactivates a resistant bacterium by rupturing its membrane may leave its resistance gene intact in the released DNA, still able to transform other bacteria. Attenuating the ARGs themselves — damaging the DNA, not just the cell — generally demands a higher field and energy dose than simple inactivation, so AMR-targeted PEF is designed to a more stringent endpoint than ordinary disinfection.

This is why microbial and AMR PEF runs at the fierce field strengths the Schwan equation demands for small, robust bacteria — tens to over a hundred kilovolts per centimetre — delivered by Marx-based or solid-state pulsed-power sources. Treating biopharmaceutical fermentation wastewater and landfill leachate to inactivate resistant organisms and attenuate their resistance genes is an active research frontier, combining the high-field PEF physics of this chapter with the kinetics of Section 28-4 and careful measurement of both viable counts and gene copies. It is a striking arc: the high-voltage engineering that began this course as a way to move power now offers a tool against one of medicine's gravest threats.

Section 28-8

Biomedical Applications and nsPEF

Turn the dose down to the reversible regime and PEF becomes a precision delivery tool. Briefly opening a cell's membrane lets large molecules that could never cross it pass inside: this is electroporation-mediated gene delivery (transfection and DNA vaccination) and electrochemotherapy, in which a pulse opens tumour cells to admit a chemotherapy drug at far lower systemic doses. Turn the dose back up to the irreversible regime, and PEF becomes a non-thermal scalpel: irreversible electroporation (IRE) ablates a tumour by killing its cells outright while sparing the collagen scaffolding of nearby blood vessels and ducts that heat-based ablation would destroy — valuable near delicate structures.

The newest frontier shortens the pulse drastically. Nanosecond pulsed electric fields (nsPEF) use pulses shorter than the membrane charging time \(\tau\), so the outer membrane never fully charges and the field reaches inside the cell, acting on the nucleus and organelles to trigger programmed cell death (apoptosis) — a promising and very active cancer-therapy avenue. From the factory to the clinic, the same electroporation physics, scaled in dose and pulse length, does the work. And as these pulsed systems proliferate — in plants, utilities and hospitals — they too become assets to be monitored, optimised and managed intelligently, which is the subject of the final chapter.

Section 28-9

Worked Examples

1 Threshold field from the Schwan equation

Problem. Taking the electroporation threshold as \(\Delta V_m = 1~\mathrm{V}\), find the field needed to porate a bacterium of radius \(r = 0.5~\mu\mathrm{m}\), and compare with a mammalian cell of \(r = 10~\mu\mathrm{m}\).

Solution. At the pole and steady state, \(\Delta V_m = 1.5\,rE\), so \(E = \Delta V_m/(1.5\,r)\):

Working
\[ E_{\text{bact}} = \frac{1}{1.5(0.5\times10^{-6})} \approx 1.3\times10^{6}~\mathrm{V/m} = 13~\mathrm{kV/cm}, \quad E_{\text{mamm}} = \frac{1}{1.5(10\times10^{-6})} \approx 0.67~\mathrm{kV/cm} \]

The tiny bacterium needs about 13 kV/cm — twenty times the mammalian cell's threshold — and robust microbes need more still, which is why AMR treatment reaches well over \(100~\mathrm{kV/cm}\).

2 Membrane charging time

Problem. For a bacterium \(r = 1~\mu\mathrm{m}\), membrane capacitance \(C_m = 0.01~\mathrm{F/m^2}\), and \(\rho_i = \rho_e = 1~\Omega\!\cdot\!\mathrm{m}\), find the charging time constant and comment on a \(2~\mu\mathrm{s}\) pulse.

Solution. Use \(\tau = r\,C_m(\rho_i + \tfrac12\rho_e)\):

Working
\[ \tau = (1\times10^{-6})(0.01)(1 + 0.5) = 1.5\times10^{-8}~\mathrm{s} = 15~\mathrm{ns} \]

At \(15~\mathrm{ns}\), the membrane is fully charged within the first fraction of a \(2~\mu\mathrm{s}\) pulse — so a microsecond pulse is far longer than needed for charging, and its extra length serves to hold the pores open.

3 Log reduction and survival

Problem. A PEF treatment achieves \(\log_{10}(N/N_0) = -4.5\). Find the surviving fraction and the percentage inactivated.

Solution. Survival \(s = 10^{\log s}\):

Working
\[ s = 10^{-4.5} \approx 3.2\times10^{-5} \;\Rightarrow\; \text{inactivated} = (1-s)\times100\% \approx 99.997\% \]

A 4.5-log reduction leaves about 3 survivors per 100,000 — \(99.997\%\) inactivation, near the \(5\)-log target used for pasteurisation-equivalent claims.

4 The Hülsheger model

Problem. With \(E_c = 8~\mathrm{kV/cm}\), \(k = 10~\mathrm{kV/cm}\), \(t_c = 1~\mu\mathrm{s}\), find the survival at \(E = 20~\mathrm{kV/cm}\), \(t = 100~\mu\mathrm{s}\).

Solution. Use \(\log s = -\dfrac{E-E_c}{k}\log\dfrac{t}{t_c}\):

Working
\[ \log s = -\frac{20-8}{10}\,\log\frac{100}{1} = -(1.2)(2) = -2.4 \;\Rightarrow\; s \approx 4\times10^{-3} \]

About a 2.4-log reduction. Raising the field widens \((E-E_c)\) and steepens the kill — the lever the designer pulls hardest, since the field enters above the threshold \(E_c\).

5 Specific energy and temperature rise

Problem. A treatment deposits a specific energy of \(40~\mathrm{kJ/kg}\) (\(\approx40~\mathrm{kJ/L}\) for water). Find the temperature rise (\(c_p = 4.18~\mathrm{kJ/kg\cdot K}\)).

Solution. The Joule heat raises the temperature by \(\Delta T = W/c_p\):

Working
\[ \Delta T = \frac{40}{4.18} \approx 9.6~\mathrm{K} \]

A rise of about 10 °C — modest, and the reason PEF counts as non-thermal, but enough that high-dose processes pre-cool the feed to keep the product cool and the treatment in the non-thermal regime.

Review

Chapter Summary

Electroporation

A strong field opens membrane pores non-thermally; a gentle dose reseals (reversible), a strong one does not (irreversible).

Schwan equation

\(\Delta V_m = 1.5\,rE\cos\theta(1-e^{-t/\tau})\); threshold \(\sim1~\mathrm{V}\); small cells need high fields.

Parameters

Field, duration, number, shape and specific energy; the membrane charges over \(\tau\), so pulses must outlast it.

Kinetics

Log-linear \(-t/D\), curved Weibull \(-(t/\delta)^p\), and Hülsheger with a critical field \(E_c\) and time \(t_c\).

Chamber & dose

Parallel-plate or co-field chambers; specific energy sets the kill and the temperature rise to be controlled.

Applications

Food pasteurising and extraction; chemical-free water disinfection and AMR/ARG attenuation; gene delivery, IRE and nsPEF.

Practice

Problems

For each item, first identify what it tests — the electroporation idea, the Schwan equation, pulse parameters, the kinetic models, the chamber and dose, or an application — then apply it. Difficulty rises down the list.

  1. Explain electroporation and why PEF treatment is described as non-thermal.
  2. State the Schwan equation and explain the meaning of each factor, including why \(\Delta V_m\) is greatest at the poles.
  3. Explain why small bacteria require much higher fields than large mammalian cells to electroporate.
  4. A cell of radius \(r = 5~\mu\mathrm{m}\) sits in \(E = 5~\mathrm{kV/cm}\). Find the peak induced transmembrane voltage and say whether it exceeds a \(1~\mathrm{V}\) threshold.
  5. For \(r = 1~\mu\mathrm{m}\), \(C_m = 0.01~\mathrm{F/m^2}\), \(\rho_i = \rho_e = 0.8~\Omega\!\cdot\!\mathrm{m}\), find the charging time constant.
  6. A treatment gives \(\log_{10}(N/N_0) = -3\). Find the surviving fraction and the percentage inactivated.
  7. Using Hülsheger with \(E_c = 7~\mathrm{kV/cm}\), \(k = 8~\mathrm{kV/cm}\), \(t_c = 1~\mu\mathrm{s}\), find the survival at \(E = 15~\mathrm{kV/cm}\), \(t = 50~\mu\mathrm{s}\).
  8. A process deposits \(60~\mathrm{kJ/kg}\) in water. Find the temperature rise and comment on the non-thermal claim.
  9. Explain why attenuating antibiotic-resistance genes generally needs a higher dose than simply inactivating the bacteria.
  10. Distinguish reversible from irreversible electroporation and give one biomedical application of each, then explain what nsPEF adds.
Tip: this whole chapter unfolds from one equation and one choice. The equation is Schwan's \(\Delta V_m = 1.5\,rE\cos\theta(1-e^{-t/\tau})\): a field charges the membrane like a capacitor, hardest at the poles, and once \(\Delta V_m\) passes \(\sim1~\mathrm{V}\) the membrane porates — with small cells needing big fields. The choice is the dose: gentle and the pores reseal (reversible — gene delivery, electrochemotherapy), harsh and they do not (irreversible — microbial kill, tumour ablation). Wrap those in the kinetic models, a uniform-field chamber and a controlled energy dose, and the same high-voltage pulse pasteurises juice, disinfects water, fights antibiotic resistance and treats cancer. The closing chapter asks how all of this modern apparatus is kept healthy through smart asset management.